CD200R1L Antibody (2692A) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10198W
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry, Immunohistochemistry
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2692A
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived mouse CD200R1L
Ile25-Thr220
Accession # Q6XJV6.1
Ile25-Thr220
Accession # Q6XJV6.1
Specificity
Detects mouse CD200R1L in direct ELISAs.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for CD200R1L Antibody (2692A) [DyLight 650]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD200R1L
Long Name
CD200 Receptor 1 Like
Alternate Names
CD200R2, CD200RLa
Additional CD200R1L Products
Product Documents for CD200R1L Antibody (2692A) [DyLight 650]
Product Specific Notices for CD200R1L Antibody (2692A) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...